Balawag, Jeffrey A.
HRN: 21-89-40 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/14/2022
CEFALEXIN 500MG CAP
09/14/2022
09/21/2022
ORAL
500mg
TID
Multiple Abrasions
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes